REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Daewoong Co.,Ltd. (Seongnam) (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Management of Companies and Enterprises
Full name: Daewoong Co.,Ltd. Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Daewoong Co.,Ltd. is engaged in manufacturing and distribution of pharmaceutical products including Olmetec, Gliatilin, and other products. The company's headquarters is located in Seongnam, Gyeonggi-do Province, South Korea. Daewoong Co.,Ltd. was incorporated in 1961.

Headquarters
223-23 Sangdaewon-Dong, Joongwon-Gu, Seongnam-Si
Seongnam; Gyeonggi; Postal Code: 462-120

Contact Details: Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.

Website: http://www.daewoong.com

Basic Information
Total Employees:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Outstanding Shares:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Registered Capital:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Financial Auditors:
Purchase the Daewoong Co.,Ltd. (Seongnam) report to view the information.
Incorporation Date:
January 10, 1961
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
11.61%
Purchase this report to view the information.
10.51%
Purchase this report to view the information.
9.7%
Purchase this report to view the information.
9.21%
Purchase this report to view the information.
5.42%
Subsidiaries
Daewoong Pharmaceutical Co.,Ltd.
40.73%
Daewoong America Inc
Daewoong Bio Indonesia
Company Performance
Financial values in the chart are available after Daewoong Co.,Ltd. (Seongnam) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.86%▲
Total operating revenue
8.22%▲
Operating profit (EBIT)
33.88%▲
EBITDA
6.87%▲
Net Profit (Loss) for the Period
59.18%▲
Total assets
9.28%▲
Total equity
12.29%▲
Operating Profit Margin (ROS)
2.28%▲
Net Profit Margin
3.46%▲
Return on Equity (ROE)
3.92%▲
Debt to Equity Ratio
-3.55%▼
Quick Ratio
-0.5%▼
Cash Ratio
-0.14%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Chong Kun Dang Pharmaceutical Corp.
 
Kwang Dong Pharmaceutical Co.,Ltd.
Hanmi Pharm. Co.,Ltd.
 
Daewoong Pharmaceutical Co.,Ltd.
Hanmi Science Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo